Lynwood Capital Management Inc.

Overview

• HeadquartersToronto, Canada²
• Legal formbusiness corporation²
• LEI254900QBWHCQ263YKN37²
• StatusActive²
• LEI statusIssued and current²
• Registered address200 Bay Street, M5J 2J1 Toronto, Canada²
• Registered withCorporations Canada, 1048381-8²

See how the biggest companies compare on our leaderboards

Corporate structure

Lynwood Capital Management Inc. sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

Timeline

1. Nov 6, 2017Founded Lynwood Capital Management Inc. is founded²

Filings

12 filings to the SEC since October 2021: 12 other. The latest 12:

1. Aug 30, 2024N-PX EDGAR
2. May 10, 202413F-HR EDGAR
3. Feb 14, 202413F-HR EDGAR
4. Nov 1, 202313F-HR EDGAR
5. Aug 14, 202313F-HR EDGAR
6. May 15, 202313F-HR/A EDGAR
7. May 12, 202313F-HR EDGAR
8. Feb 7, 202313F-HR EDGAR
9. Oct 25, 202213F-HR EDGAR
10. Aug 2, 202213F-HR EDGAR
11. May 5, 202213F-HR EDGAR
12. Feb 11, 202213F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Lynwood Capital Management Inc. has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

• KAZIA THERAPEUTICS LTDSCHEDULE 13G/A Jan 23, 2026 to Aug 14, 2026³
• Rein Therapeutics, Inc.SCHEDULE 13G/A May 8, 2026 to Aug 14, 2026⁴
• BriaCell Therapeutics Corp.SC 13G/A Feb 11, 2022 to Feb 14, 2023⁵